Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
Avi J. Samelson, Quang Tran, Rémy Robinot, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 1, pp. 24-34
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 382
AI-powered therapeutic target discovery
Frank W. Pun, Ivan V. Ozerov, Alex Zhavoronkov
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 9, pp. 561-572
Open Access | Times Cited: 131
A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 1, pp. 128-139
Open Access | Times Cited: 124
Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target
Jiandong Shi, Tingfu Du, Junbin Wang, et al.
Science Advances (2023) Vol. 9, Iss. 22
Open Access | Times Cited: 27
Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection
Kendra R. Vann, Arpan Acharya, Suk Min Jang, et al.
Structure (2022) Vol. 30, Iss. 9, pp. 1224-1232.e5
Open Access | Times Cited: 29
PCIF1-mediated deposition of 5′-cap N 6 ,2′- O -dimethyladenosine in ACE2 and TMPRSS2 mRNA regulates susceptibility to SARS-CoV-2 infection
Lingling Wang, Shaobo Wang, Lujing Wu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 5
Open Access | Times Cited: 20
Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants
Roshan Vaid, Akram Mendez, Ketan Thombare, et al.
Genome Research (2023) Vol. 33, Iss. 3, pp. 299-313
Open Access | Times Cited: 18
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq
Sara Sunshine, Andreas S. Puschnik, Joseph M. Replogle, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Targeting bromodomain-containing proteins: research advances of drug discovery
Zhaoping Pan, Yuxi Zhao, Xiaoyun Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 16
Alkenyl oxindole is a novel PROTAC moiety that recruits the CRL4DCAF11 E3 ubiquitin ligase complex for targeted protein degradation
Ying Wang, Tianzi Wei, Man Zhao, et al.
PLoS Biology (2024) Vol. 22, Iss. 5, pp. e3002550-e3002550
Open Access | Times Cited: 6
New perspective of small-molecule antiviral drugs development for RNA viruses
Shasha Li, Huixia Li, Ruiya Lian, et al.
Virology (2024) Vol. 594, pp. 110042-110042
Closed Access | Times Cited: 5
Machine learning-aided search for ligands of P2Y6 and other P2Y receptors
Ana C. Puhl, Sarah A. Lewicki, Zhan‐Guo Gao, et al.
Purinergic Signalling (2024)
Open Access | Times Cited: 5
Large-scale CRISPRi screens link metabolic stress to glioblastoma chemoresistance
Xing Li, Wansong Zhang, Yitong Fang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Identification of genetic modifiers enhancing B7-H3-targeting CAR T cell therapy against glioblastoma through large-scale CRISPRi screening
Xing Li, Shiyu Sun, Wansong Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
H2A.Z's ‘social’ network: functional partners of an enigmatic histone variant
Carlotta Kreienbaum, Lena W. Paasche, Sandra B. Hake
Trends in Biochemical Sciences (2022) Vol. 47, Iss. 11, pp. 909-920
Closed Access | Times Cited: 21
SARS-CoV-2 and the Nucleus
Mengqi Chen, Yue Ma, Wakam Chang
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4731-4743
Open Access | Times Cited: 21
Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches
Swati Bhat, Praveen Rishi, Vijayta Dani Chadha
Virus Research (2022) Vol. 318, pp. 198853-198853
Open Access | Times Cited: 18
Identification of Human Host Substrates of the SARS-CoV-2 Mpro and PLpro Using Subtiligase N-Terminomics
Shu Luo, Eman W. Moussa, Joaquín López-Orozco, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 4, pp. 749-761
Open Access | Times Cited: 11
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11
Computational screening of potential bromodomain-containing protein 2 inhibitors for blocking SARS-CoV-2 infection through pharmacophore modeling, molecular docking and molecular dynamics simulation
Shaohua Xu, Huicheng Yuan, Ling Li, et al.
Arabian Journal of Chemistry (2023) Vol. 17, Iss. 1, pp. 105365-105365
Open Access | Times Cited: 11
Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders
Hevna Dhulkifle, Mohammad Diab, Majed Ali Algonaiah, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 546-559
Open Access | Times Cited: 3
PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
Arpan Acharya, Anup S. Pathania, Kabita Pandey, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 18
Gene Modulation with CRISPR-based Tools in Human iPSC-Cardiomyocytes
Julie Han, Emilia Entcheva
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 4, pp. 886-905
Open Access | Times Cited: 8
Association Between ACE2 and Lung Diseases
Cheng Su, Li Cai, Xinyi Hu, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 1771-1780
Open Access | Times Cited: 2
A human iPSC-array-based GWAS identifies a virus susceptibility locus in the NDUFA4 gene and functional variants
Yuling Han, Lei Tan, Ting Zhou, et al.
Cell stem cell (2022) Vol. 29, Iss. 10, pp. 1475-1490.e6
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top